Search

Your search keyword '"Gemicioğlu B"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Gemicioğlu B" Remove constraint Author: "Gemicioğlu B"
128 results on '"Gemicioğlu B"'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

3. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

4. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

5. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

6. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

7. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

8. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

9. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

10. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

11. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

12. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

13. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

14. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

15. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

16. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

17. Management of anaphylaxis due to COVID-19 vaccines in the elderly

18. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

19. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

20. COVID-19 pandemic and the global perspective of turkish thoracic society

21. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

22. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

23. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

24. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

25. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

26. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

28. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

29. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

30. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

31. MASK (Mobile airways sentinel network) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity [Türkiye’de MASK (Mobile airways sentinel network) allerji günlüğü uygulaması: Allerjik rinit ve astımda ARIA ile bütünleşmiş mobil teknoloji kullanımı]

33. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

34. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

35. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

36. Aria 2016 Executive Summary: Integrated Care Pathways For Predictive Medicine Across The Life Cycle | Aria 2016 Yönetici Özeti: Yaşam Döngüsü Boyunca Hastalıkları Öngörmeye Yönelik Tıp Uygulamaları Için Bütünleştirilmiş Yaklaşım Yolakları

37. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

38. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

39. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

40. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

41. Evaluation of asthma and COPD awareness in primary care doctors in Turkey [Türkiye’de birinci basamak hekimlerinde astım ve KOAH farkındalığının değerlendirilmesi]

42. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

43. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

44. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

45. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

46. Asthma-KOAH overlap syndrome [Astım-KOAH overlap sendromu]

47. Koah ve astımda atak [KOAH ve astımda atak]

48. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

49. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

50. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study

Catalog

Books, media, physical & digital resources